Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atopis
Auckland, Auckland, New Zealandatopis.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Atopis is a New Zealand-based biotechnology company specializing in scientifically-backed skincare solutions derived from botanical fermentation. Founded by Dr. Iona Weir, the company utilizes its patented Myrecil platform to create products that modulate the skin microbiome and immune response. Their portfolio targets common dermatological conditions such as acne, eczema, and rosacea, as well as anti-aging. Atopis emphasizes a nature-meets-science approach, leveraging clinical research to validate the efficacy of its topical treatments.
- Therapeutic areas
- OtherDermatology
- Modalities
- Botanical extractTopical
- Industry
- Biotech
Beyond the preview
Go deeper on Atopis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atopis.